ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2014

Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.

Carole Dembek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.